KEGG   Prionailurus viverrinus (fishing cat): 125166021
Entry
125166021         CDS       T09889                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
pviv  Prionailurus viverrinus (fishing cat)
Pathway
pviv01522  Endocrine resistance
pviv01524  Platinum drug resistance
pviv04012  ErbB signaling pathway
pviv04066  HIF-1 signaling pathway
pviv04068  FoxO signaling pathway
pviv04110  Cell cycle
pviv04115  p53 signaling pathway
pviv04151  PI3K-Akt signaling pathway
pviv04218  Cellular senescence
pviv04630  JAK-STAT signaling pathway
pviv04921  Oxytocin signaling pathway
pviv04928  Parathyroid hormone synthesis, secretion and action
pviv04934  Cushing syndrome
pviv05160  Hepatitis C
pviv05161  Hepatitis B
pviv05163  Human cytomegalovirus infection
pviv05165  Human papillomavirus infection
pviv05166  Human T-cell leukemia virus 1 infection
pviv05167  Kaposi sarcoma-associated herpesvirus infection
pviv05169  Epstein-Barr virus infection
pviv05200  Pathways in cancer
pviv05202  Transcriptional misregulation in cancer
pviv05203  Viral carcinogenesis
pviv05205  Proteoglycans in cancer
pviv05206  MicroRNAs in cancer
pviv05210  Colorectal cancer
pviv05211  Renal cell carcinoma
pviv05212  Pancreatic cancer
pviv05213  Endometrial cancer
pviv05214  Glioma
pviv05215  Prostate cancer
pviv05216  Thyroid cancer
pviv05217  Basal cell carcinoma
pviv05218  Melanoma
pviv05219  Bladder cancer
pviv05220  Chronic myeloid leukemia
pviv05222  Small cell lung cancer
pviv05223  Non-small cell lung cancer
pviv05224  Breast cancer
pviv05225  Hepatocellular carcinoma
pviv05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:pviv00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    125166021 (CDKN1A)
   04630 JAK-STAT signaling pathway
    125166021 (CDKN1A)
   04066 HIF-1 signaling pathway
    125166021 (CDKN1A)
   04068 FoxO signaling pathway
    125166021 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    125166021 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    125166021 (CDKN1A)
   04115 p53 signaling pathway
    125166021 (CDKN1A)
   04218 Cellular senescence
    125166021 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    125166021 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    125166021 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    125166021 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    125166021 (CDKN1A)
   05206 MicroRNAs in cancer
    125166021 (CDKN1A)
   05205 Proteoglycans in cancer
    125166021 (CDKN1A)
   05203 Viral carcinogenesis
    125166021 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    125166021 (CDKN1A)
   05212 Pancreatic cancer
    125166021 (CDKN1A)
   05225 Hepatocellular carcinoma
    125166021 (CDKN1A)
   05226 Gastric cancer
    125166021 (CDKN1A)
   05214 Glioma
    125166021 (CDKN1A)
   05216 Thyroid cancer
    125166021 (CDKN1A)
   05220 Chronic myeloid leukemia
    125166021 (CDKN1A)
   05217 Basal cell carcinoma
    125166021 (CDKN1A)
   05218 Melanoma
    125166021 (CDKN1A)
   05211 Renal cell carcinoma
    125166021 (CDKN1A)
   05219 Bladder cancer
    125166021 (CDKN1A)
   05215 Prostate cancer
    125166021 (CDKN1A)
   05213 Endometrial cancer
    125166021 (CDKN1A)
   05224 Breast cancer
    125166021 (CDKN1A)
   05222 Small cell lung cancer
    125166021 (CDKN1A)
   05223 Non-small cell lung cancer
    125166021 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    125166021 (CDKN1A)
   05161 Hepatitis B
    125166021 (CDKN1A)
   05160 Hepatitis C
    125166021 (CDKN1A)
   05163 Human cytomegalovirus infection
    125166021 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    125166021 (CDKN1A)
   05169 Epstein-Barr virus infection
    125166021 (CDKN1A)
   05165 Human papillomavirus infection
    125166021 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    125166021 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    125166021 (CDKN1A)
   01522 Endocrine resistance
    125166021 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 125166021
NCBI-ProteinID: XP_047715578
LinkDB
Position
B2:35265140..35273925
AA seq 164 aa
MSEPSRDAHQIPHGSKACRRLFGPVDSEQLRRDCDALMAGCVQEARERWNFDFVTETPLE
GDFAWERVWGLSLPKLYLPAGPRGGRDDLGGGKRPSTSSTLLPGTAREDHLDLSLSCTLM
PHSPERPEASPGAPGTSQGRKRRQTSMTDFYHSKRRLIFSKRKP
NT seq 495 nt   +upstreamnt  +downstreamnt
atgtcggagccgtccagggatgcccaccagatcccacatggcagcaaggcctgccgccgc
ctctttggcccagtggacagcgagcagctgcgccgagactgtgacgcgttaatggcaggc
tgcgtgcaggaggcccgggagcgatggaacttcgactttgtcaccgagacaccgctggag
ggcgactttgcctgggagcgtgtgtggggcctgagcctgcccaagctctacctgcctgca
gggccccgggggggccgggatgacctgggagggggcaagcggcccagcacctcgtctacc
ctgctgccggggacagctcgggaggaccacctggacctgtccctgtcctgcactctcatg
cctcactcccctgagcggcccgaggcgtctccgggtgcacctggcacctctcagggccga
aaacggcggcagaccagcatgacagatttctatcactccaaacgccggctgatcttctcc
aagaggaagccctaa

DBGET integrated database retrieval system